^
Association details:
Evidence:
Evidence Level:
Resistant: D – Preclinical
Title:

The Absence of PTEN in Breast Cancer Is a Driver of MLN4924 Resistance

Published date:
04/30/2021
Excerpt:
Our data show that the anti-tumor efficacy of MLN4924 in breast cancer cells was markedly reduced with the deletion of PTEN...PTEN status thus may help to identify MLN4924-responsive breast cancer patients.
DOI:
10.3389/fcell.2021.667435